2022年1月16日日曜日
GCA (企業)
（GCAサヴィアングループから転送）
2022年1月8日土曜日
COVID-19 vaccine website and patent infringement
Deloitte was awarded a $44 million no-bid contract by the Centers for Disease Control and Prevention (CDC) in the United States to build a website to manage scheduling, inventory, and reporting for COVID-19 vaccination.[103] However, the website functioned poorly, leading very few states to adopt it for their vaccination management.[104][103]
In August 2020 a patent attorney for Tiffany Tate, the executive director of the Multi-State Partnership for Prevention (MSPP), issued a cease and desist letter accusing Deloitte and the CDC of stealing Tate's intellectual property for a mass vaccination tracker for use in tracking vaccinations for COVID-19. Tate earlier had demonstrated software to the CDC that would help automate key aspects of delivering mass vaccinations. Deloitte was present during that presentation and was identified by the CDC as a consultant. Eventually Deloitte received the technical specifications of the software. At the time that Tate demonstrated the software, the CDC indicated that it "did not have a workflow for handling vaccine distribution". Less than one week later the CDC announced its intention to build tracking software. Under the Trump administration the CDC awarded a no bid contract to Deloitte to build a vaccine administration management system, even though MSPP had offered such a system at a lower price. Later the CDC awarded a second contract to Deloitte, with both contracts totaling US$43.9 million. Tate's attorney said that Deloitte's system "has the identical structure, mirrors the functionality, and duplicates the same features" as MSPP's system. The attorney also commented that Deloitte tried to hire Ms. Tate to work on the project.[105][106]
1 件のコメント:
繋がっちゃうもんDEATHネ
繋がりあるからこそ繋がるかー
コメントを投稿